Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Merck & Co
(NY:
MRK
)
131.20
+0.48 (+0.37%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Merck & Co
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
65
66
Next >
7 Biotech Stocks to Buy for Big-Time Gains
November 10, 2023
Biotech stocks can be big winners because they're at the forefront of scientific innovation and push the boundaries of medical research.
Via
InvestorPlace
7 Safe Stocks to Buy if You Think Q3’s Gangbuster Growth Won’t Last
November 09, 2023
Although the Q3 U.S. GDP print came in much hotter than expected, the momentum might not last, thus incentivizing safe stocks.
Via
InvestorPlace
10 Analysts Have This to Say About Merck & Co
November 09, 2023
Via
Benzinga
BioXcel Therapeutics Reveals Survival Data From Prostate Cancer Combo Therapy Trial
November 08, 2023
BioXcel Therapeutics Inc (NASDAQ: BTAI) announced overall survival (OS) data from its Phase 2 trial of BXCL701 in combination with Merck & Co Inc's (NYSE: MRK) Keytruda (pembrolizumab) in patients wi
Via
Benzinga
Mizuho's Top Stock Picks For November Revealed
November 05, 2023
As trading for November begins, Mizuho recommends a few stocks for investors to consider.
Via
Benzinga
Merck & Co Unusual Options Activity For November 03
November 03, 2023
Via
Benzinga
A Look Into Merck & Co Inc's Price Over Earnings
November 01, 2023
Via
Benzinga
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
October 30, 2023
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Down 84% From Its Peak. Is It Finally Time to Buy Moderna?
November 05, 2023
The vaccine developer's huge profits have turned into heavy losses.
Via
The Motley Fool
3 Trustworthy Blue-Chip Stocks to Buy Now
November 04, 2023
Considering the economic and geopolitical uncertainty, seek safety in these blue-chip stocks to buy with earnings and dividend growth.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
November 02, 2023
Via
Benzinga
Moderna Beats Sales Forecasts, But Light Guidance Could Rattle Shares
November 02, 2023
The company issued below-consensus sales views for 2023 and 2024.
Via
Investor's Business Daily
3 Dividend Stocks That Could Raise Their Payouts in November
November 02, 2023
Should you add these income-generating stocks to your portfolio?
Via
The Motley Fool
Check Out What Whales Are Doing With MRK
October 23, 2023
Via
Benzinga
Healthcare Playbook: Hardly Defensive With A Covid Hangover In Biotech
November 01, 2023
Market Bubbles may take a long time to clear and we created a big one in July 2021 dealing with the COVID pandemic.
Via
Talk Markets
Exposures
COVID-19
Merck's Blockbuster Cancer Drug Keytruda Secures FDA Approval For Biliary Tract Cancer
November 01, 2023
The FDA approved Merck & Co Inc's (NYSE: MRK) Keytruda, in combination with gemcitabine and cisplatin, for locally advanced unresectable or
Via
Benzinga
Exposures
Product Safety
Merck Just Made a Big Move -- but Will It Be Enough for Investors Right Now?
October 31, 2023
In due time, its new partnership with Daiichi Sankyo could be massive.
Via
The Motley Fool
Jim Cramer Says Hold Onto This Tech Stock, But 'You're Not Going To Make A Lot Of Money In It Right Now, Because That Was A Really Terrible Last Quarter'
October 31, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Corning Incorporated (NYSE: GLW) reported a disappointing quarter.
Via
Benzinga
2 No-Brainer AI Stocks to Buy and One to Run Away From
October 31, 2023
Artificial intelligence is altering the business landscape and opening up unique AI stocks to buy as well as ones to avoid.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Week In Review: Hansoh Sells Ex-China ADC Rights To GSK In $1.6 Billion Deal
October 28, 2023
Hansoh Pharma sold ex-China rights for its B7-H4 ADC to GSK in a $1.57 billion deal. Meanwhile, OrbiMed has raised $4.3 billion in commitments for three healthcare funds, including $751 million for its...
Via
Talk Markets
3 Deeply Undervalued Growth Stocks
October 27, 2023
As in 2022, the current downturn of stocks appears to be way overdone, making this a good time to buy undervalued growth stocks.
Via
InvestorPlace
Stock Market Correction Intensifies; Google, Meta, Microsoft, Amazon Are Big Earnings Movers: Weekly Review
October 27, 2023
Microsoft, Google, Amazon and Meta led big earnings.
Via
Investor's Business Daily
Merck (MRK) Q3 2023 Earnings Call Transcript
October 26, 2023
MRK earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why Pharma Giant Merck's Shares Are Shooting Higher Today
October 26, 2023
Merck & Company, Inc. (NYSE: MRK) Q3 sales reached $15.962 billion, up 7% Y/Y, beating the consensus of $15.320 billion,
Via
Benzinga
Here's How Merck's Heavyweight Cancer Drug Helped Deliver Another Beat-And-Raise Quarter
October 26, 2023
The company lowered its earnings outlook, however, due to a new development deal with Daiichi Sankyo.
Via
Investor's Business Daily
Nasdaq Futures Plunge As Meta Warns Of Q4 Softness: GDP Data, Amazon Earnings On Investors' Radar Amid Market Mayhem
October 26, 2023
Stock futures are plunging after the mega-cap tech names haven't turned in the strong results that the markets had factored in.
Via
Benzinga
Pivotal Week Coming Up: Big Tech Earnings, Geopolitics, Technicals, Treasury Yield...
October 23, 2023
The upcoming quarter GDP is expected to hit 3.7% which has brought the FED dialogue to “higher rates for longer” which might lead us to a recession in 2024. So watch the yield on the 10-year TSY now at...
Via
Talk Markets
Topics
Economy
Exposures
Economy
Roche Spends $7.1 Billion On Roivant Drug, Following Merck, Sanofi Into The Raging Hot Immunology Space
October 23, 2023
Roche is joining Merck and Sanofi in the TL1A drug space. These drugs could treat stomach diseases.
Via
Investor's Business Daily
How This New Merck Regimen Could 'Rewrite Textbooks' In Cancer Treatment — And Bolster 4 Stocks
October 22, 2023
The companies studied a combination of Keytruda and Padcev in bladder cancer patients.
Via
Investor's Business Daily
Amazon, Alphabet, Meta, Intel Q3 Earnings This Week: Will Mega-Caps Shatter Forecasts And Revive Market?
October 23, 2023
Factset data indicates that out of the 17% of the S&P 500 companies that have reported so far, 73% have reported positive EPS surprises.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
65
66
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.